DermTech: demand to strengthen pharma partnerships over next 5 years

By Melissa Fassbender contact

- Last updated on GMT

DermTech’s patented platform technology support compound advancement through the clinical stages of development.(Image: iStock/Pixtum)
DermTech’s patented platform technology support compound advancement through the clinical stages of development.(Image: iStock/Pixtum)

Related tags: Medicine

DermTech, Inc. has announced two new collaborations with pharmaceutical companies and expects more to follow as the demand for personalized, precision medicine increases.

DermTech develops non-invasive gene expression tests to support skin cancer diagnosis, assess inflammatory diseases, and personalize drug treatment.

The company’s technology enables the analysis of skin biopsy samples collected non-invasively using an adhesive patch.

Dr. Burkhard Jansen, Chief Medical Officer at DermTech, told Outsourcing-Pharma.com, “An increasing number of pharma and large biotech partners are recognizing the value Dermtech’s non-invasive gene expression platform offers to their development efforts through molecular dermatology​.”

In Q1 of 2017, the company has added three new “large​” partnerships, Jansen explained.

Existing partners generally add programs and expand the scope of projects after they see the extent of what the platform can offer​,” he added.

The collaborations have generally entailed non-invasive tissue collection and gene expression analyses for various skin conditions, with and without systemic or topical therapeutic intervention.

Per the company's website​, current clinical collaborations include MedImmune, Biogen, and Johnsons & Johnson, among others.

While our pharma relationships expand, we are also seeing increasing interest from small to midsize biotech companies and from NGO partners​,” said Jansen.

We expect the continuing demand for personalized, precision medicine to further strengthen DermTech’s pharma partnerships over the next five years​.”

Related news

Related products

show more

What should a clinical metadata repository do?

What should a clinical metadata repository do?

Formedix | 26-Jul-2021 | Technical / White Paper

Choosing a clinical metadata repository (MDR) software can be a tough task as the capabilities and features of your chosen MDR could make or break your...

Adapting supply chains to new ways of working

Adapting supply chains to new ways of working

World Courier | 15-Jul-2021 | Technical / White Paper

COVID-19 has changed the way we operate. We have adapted our supply chain solutions to meet our clients’ requirements while following World Courier standard...

Empowering Clinical Trial Sponsors with Analytics

Empowering Clinical Trial Sponsors with Analytics

PerkinElmer | 14-Jul-2021 | Technical / White Paper

Is your Clinical Data Review creating problems or solving them? Take Control of Your Data. PerkinElmer Informatics Clinical Solutions, powered by Tibco...

What are the building blocks of DCTs?

What are the building blocks of DCTs?

Medable | 26-Apr-2021 | Technical / White Paper

How to create a seamless experience across eConsent, eCOA and more.

Over the past year, tremendous progress was made toward digitizing and...

Related suppliers

Follow us

Products

View more

Webinars